Ep0092 644 — Minneapolis, Minnesota

Ep0092 644 is a clinical research site located in Minneapolis, Minnesota, United States 55416.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Ep0092 644 has participated in 1 clinical trials.

Therapeutic areas: Drug-Resistant Epilepsy, Focal-Onset Seizures.

Sponsors: UCB Biopharma SRL.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Minneapolis

Browse all research sites in Minnesota · View every site in Minneapolis

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ep0092 644?

Ep0092 644 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ep0092 644 conducted?

Ep0092 644 has 1 clinical trials on record. Their work covers Drug-Resistant Epilepsy, Focal-Onset Seizures.

Is Ep0092 644 accredited by Crixeo Clinical Trials?

Ep0092 644 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ep0092 644?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.